Blackhill Capital Inc’s Bristol-Myers Squibb Co Position
Does Blackhill Capital Inc own Bristol-Myers Squibb Co (BMY)? Yes — 275.4K shares worth $17M (+0.86% of its 13F portfolio) as of Q1 2026, down from 280.6K shares the prior filed quarter.
Position Value
$17M
Q1 2026
Shares
275.4K
% of Portfolio
+0.86%
Quarters Held
30
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 275.4K | $17M | +0.86% |
| Q4 2025 | 280.6K | $15M | +0.78% |
| Q3 2025 | 280.6K | $13M | +0.63% |
| Q2 2025 | 281.3K | $13M | +0.75% |
| Q1 2025 | 284.3K | $17M | +1.01% |
| Q4 2024 | 223.2K | $13M | +0.65% |
| Q3 2024 | 214.5K | $11M | +0.64% |
| Q2 2024 | 214.5K | $9M | +0.55% |
| Q1 2024 | 314.5K | $17M | +0.98% |
| Q4 2023 | 371.3K | $19M | +1.53% |
| Q3 2023 | 399.9K | $23M | +2.24% |
| Q2 2023 | 410.3K | $26M | +2.82% |
| Q1 2023 | 437.3K | $30M | +3.38% |
| Q4 2022 | 440.9K | $32M | +3.68% |
| Q3 2022 | 417.1K | $30M | +3.52% |
| Q2 2022 | 429.2K | $33M | +3.83% |
| Q1 2022 | 430.8K | $31M | +2.99% |
| Q4 2021 | 430.8K | $27M | +2.30% |
| Q3 2021 | 427.0K | $25M | +2.19% |
| Q2 2021 | 427.0K | $29M | +2.60% |
| Q1 2021 | 427.0K | $27M | +2.35% |
| Q4 2020 | 429.0K | $27M | +3.21% |
| Q3 2020 | 428.2K | $26M | +3.49% |
| Q2 2020 | 425.2K | $25M | +3.68% |
| Q1 2020 | 427.0K | $24M | +4.95% |
| Q4 2019 | 429.0K | $28M | +4.02% |
| Q3 2019 | 398.2K | $20M | +3.19% |
| Q2 2019 | 447.5K | $20M | +3.27% |
| Q1 2019 | 426.1K | $20M | +3.49% |
| Q4 2018 | 435.2K | $23M | +4.33% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Blackhill Capital Inc’s full portfolio or all institutional holders of BMY.